In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).

The in vitro susceptibilities of two clinical isolates of Chlamydia pneumoniae from Brooklyn, N.Y., were determined for tetracycline, erythromycin, sulfamethoxazole, ciprofloxacin, and three new macrolides--azithromycin, clarithromycin, and roxithromycin. Clarithromycin was the most active drug test...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Chirgwin, K, Roblin, P M, Hammerschlag, M R
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1989
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172720/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2817862/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.9.1634
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!